Misusing volatile substances for their hallucinatory effects: A qualitative pilot study with Mexican teenagers and a pharmacological discussion of their hallucinations

Substance Use and Misuse

Volumn 46, Issue SUPPL. 1, 2011, Pages 84-94

  Cruz, Silvia L ^a,b   Domínguez, Mario ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b Departamento de Farmacobiologia   (Mexico)

Author keywords

adolescents; hallucinations; illusions; Inhalants; solvents; students; toluene

Indexed keywords

SOLVENT; TOLUENE;

ADOLESCENT; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; HALLUCINATION; HUMAN; INHALANT ABUSE; INTERVIEW; MALE; MEXICO; PILOT STUDY;

ADOLESCENT; FEMALE; HALLUCINATIONS; HUMANS; INHALANT ABUSE; INTERVIEWS AS TOPIC; MALE; MEXICO; PILOT PROJECTS; SOLVENTS; TOLUENE;

EID: 79957599155     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.580222     Document Type: Article

References (41)

1. Aghajanian, G. K., & Marek, G. J. (2000). Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Research Reviews, 31, 302-312. (Pubitemid 30136185)
2. Baguley, D. M. (2002). Mechanisms of tinnitus. British Medical Bulletin, 63, 195-212. (Pubitemid 35175761)
3. Blom, J. D. (2010). A dictionary of hallucinations. New York: Springer.
4. Bonino, L. (2000). Varones, género y salud mental: deconstruyendo la "normalidad masculina" [Males, gender and mental health: deconstructing "male normality"]. In M. Sagarra & A. Carabí (Eds.), Nuevas masculinidades [Newmasculinities]. (pp. 41-64) Barcelona, Spain: Icaria.
5. Bowen, S. E., Batis, J. C., Paez-Martinez, N., & Cruz, S. L. (2006). The last decade on solvent research in animal models of abuse: Mechanistic and behavioral effects. Neurotoxicology and Teratology, 28, 636-647. (Pubitemid 44829925)
6. Brouette, T., & Anton, R. (2001). Clinical review of inhalants. The American Journal of Addictions, 10, 79-94. (Pubitemid 32201735)
7. Dodgen, C. E., & Shea, W. M. (2000). Substance use disorders: Assessment and treatment. New York: Academic Press.
8. Elliott, B., Joyce, E.,&Shorvon, S. (2009). Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena. Epilepsy Research, 85, 162-171.
9. Evans, A. C., & Raistrick, D. (1987). Phenomenology of intoxication with toluene-based adhesives and butane gas. British Journal of Psychiatry, 150, 769-773. (Pubitemid 17082034)
10. Fénelon, G. (2008). Psychosis in Parkinson's disease; phenomenology, frequency, risk factors, and current understanding of patophysiologic mechanisms. CNS Spectrum, 13, 18-25. (Pubitemid 351532445)
11. Gagnaire, F., & Langlais, C. (2005). Relative ototoxicity of 21 aromatic solvents. Archives of Toxicology, 79, 346-354. (Pubitemid 40848225)
12. Gay, M., Meller, R., & Stanley, S. (1982). Drug abuse monitoring: A survey of solvent abuse in the County of Avon. Human Toxicology, 1, 257-263. (Pubitemid 13226935)
13. Gigengack, R. (2006). Young, damned and banda: The world of young street people in Mexico City, 1990-1997. Amsterdam: University of Amsterdam.
14. González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., et al. (2007). Hallucinogens recruit specific cortical 5- HT2A receptor-mediated signaling pathways to affect behavior. Neuron, 53, 439-452. (Pubitemid 46161267)
15. Gutierrez, R., & Vega, L. (1995). Las interpretaciones, las prácticas y las reacciones sociales del uso de solventes inhalables entre los llamados niños de las calle [The social interpretations, practices and reactions to solvent use by the so-called street children]. Anales del Instituto Mexicano de Psiquiatría, 6, 140-145.
16. Halpern, J. H., & Pope, H. G., Jr. (2003). Hallucinogen persisting perception disorder: What do we know after 50 years? Drug and Alcohol Dependence, 69, 109-119. (Pubitemid 36259773)
17. Julien, R. M., Advokat, C. D., & Comaty, J. E. (2008). A primer of drug action: A comprehensive guide to the actions, uses, and side effects of psychoactive drugs (11th ed.). New York: Worth Publishers.
18. Kerner, K. (1988). Current topics in inhalant abuse. In R. A. Crider & B. A. Rouse (Eds.), Epidemiology of inhalant abuse: An update (pp. 8-29) [Monograph No. 85].Washington, DC: National Institute on Drug Abuse Research.
19. King, M. D., Day, R. E., Oliver, J. S., Lush,M.,&Watson, J. (1981). Solvent encephalopathy. British Medical Journal, 283, 663-665. (Pubitemid 11052950)
20. Lara, M. A., Galindo, G., Romero, M., Salvador, J., & Domínguez, M. (2003). La figura compleja de Rey en adolescentes que consumen inhalables [Rey's complex figure in adolescents that use inhalants]. Salud Mental, 26, 17-26. (Pubitemid 38292122)
21. López-Gil, X., Artigas, F., & Adell, A. (2010). Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. Current Pharmaceutical Design, 16, 502-515.
22. Lubman, D. I., Yücel, M., & Lawrence, A. J. (2008). Inhalant abuse among adolescents: Neurobiological considerations. British Journal of Pharmacology, 154, 316-326. (Pubitemid 351670602)
23. MacLean, S. (2005). "It might be a scummy-arsed drug but it's a sick buzz": chroming and pleasure. Contemporary Drug Problems, 32, 295-318. (Pubitemid 41148452)
24. MacLean, S. (2007). Global selves: Marginalised young people and aesthetic reflexivity in inhalant drug use. Journal of Youth Studies, 10, 399-418.
25. MacLean, S. (2008). Volatile bodies: stories of corporeal pleasure and damage in marginalised young people's drug use. International Journal of Drug Policy, 19, 375-383.
26. McGarvey, E. L., Clavet, G. J., Mason, W., & Waite, D. (1999). Adolescent inhalant abuse: Environments of use. American Journal of Drug and Alcohol Abuse, 25, 731-741. (Pubitemid 29508065)
27. Medina-Mora, M. E., Gutierrez, R., & Vega, L. (1997). What happened to street kids? An analysis of the Mexican experience. Substance Use and Misuse, 32(3), 293-316. (Pubitemid 27114180)
28. Mehling, R. (2003). Hallucinogens: Drugs the straight facts. New York: Chelsea House Publishers.
29. Meyer, J. S.,&Quenzer, L. F. (2005). Psychopharmacology: Drugs, the brain, and behavior. Sunderland, MA: Sinauer Associates.
30. Nichols, D. E. (2004). Hallucinogens. Pharmacology and Therapeutics, 101, 131-181. (Pubitemid 38167565)
31. Preble, E., & Laury, G. V. (1967). Plastic cement: The ten cent hallucinogen. The International Journal of the Addictions, 2, 271-281.
32. Press, E., & Done, A. K. (1967). Solvent sniffing: Physiologic effects and community control measures for intoxication from the intentional inhalation of organic solvents. II. Pediatrics, 39, 611-622.
33. Romero, M., & Medina-Mora, M. E. (1998). Las adicciones en mujeres: problema genéricamente construido [Addictions in women: A gender-built problem]. In C. De Agostini (Ed.), Con ganas de vivir. Una vida sin violencia es derecho nuestro [Wanting to live⋯ A life without violence is our right] (pp. 7-23). México, DF: Programa de las Naciones Unidas para la Fiscalizaci ón Internacional de Drogas/Oficina Regional para México y Centroamérica.
34. Romero, M., Rodríguez, E., Durand-Smith, A., & Aguilera, R. M. (2003). Veinticinco años de investigación cualitativa en salud mental y adicciones con poblaciones ocultas. [Twenty five years of qualitative research in mental health and addiction within hidden populations]. Salud Mental, 26, 76-83. (Pubitemid 38292127)
35. Ron, M. A. (1986). Volatile substance abuse: A review of possible long-term neurological, intellectual and psychiatric sequelae. British Journal of Psychiatry, 148, 235-246. (Pubitemid 16036685)
36. Sharp, C. W., Rosenberg, N., & Beauvais, F. (2008). Substance abuse: inhalant-related disorders. In A. Tasman, J. Kay, J. A. Lieberman, M. B. First, & M. Maj (Eds.), Psychiatry (3rd ed., pp. 1127-1148). New York: John Wiley and Sons.
37. Sourindhrin, I., & Baird, J. A. (1984). Management of solvent misuse. A Glasgow community approach. British Journal of Addiction, 79, 277-232.
38. Stahl, M. S. (2008). Stahl's essential psychopharmacology: Neurosicentific basis and practical applications (3rd ed.). New York: Cambridge University Press.
39. Takagi, M. J., Yücel, M., & Lubman, D. (2010). The dark side of sniffing: Paint color affects intoxication experiences among adolescent inhalant users. Drug and Alcohol Review, 29, 452-455.
40. Trotter, R. T. (1993). Review of Tally 3.0. Cultural Anthropology Methods, 5, 10-12.
41. Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews Neuroscience, 11, 642-651.